|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02633 JACOBSON PHARMA
Nominal 
1.290 +0.020 (+1.575%) | 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | |
| Turnover | 766,553 | -5.364% | 810,002 | 714,918 | 817,353 | 750,413 |
| Cost of Sales | (428,750) | -6.495% | (458,531) | (413,839) | (476,924) | (477,571) |
| Gross Profit | 337,803 | -3.889% | 351,471 | 301,079 | 340,429 | 272,842 |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 3,061 | 2272.868% | 129 | 332 | (2,018) | (2,100) | |
| Profit / (Loss) before Taxation | 173,535 | -1.050% | 175,377 | 118,860 | 176,768 | 101,906 | |
| Taxation | (31,500) | -10.223% | (35,087) | (21,579) | (29,400) | (19,047) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 80,609 | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | (23,850) | (11,176) | (2,820) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 142,035 | 1.244% | 140,290 | 154,040 | 136,192 | 80,039 | |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | |
| Net Finance Costs / (Income) | 8,521 | -37.465% | 13,626 | 31,510 | 18,960 | 11,984 |
| Depreciation & Amortisation | 76,533 | 7.093% | 71,464 | 71,403 | 92,711 | 97,582 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| EPS (cts) | 7.120 | 0.707% | 7.070 | 8.060 | 7.100 | 4.180 |
| DPS (cts) | 4.250 | -- | 3.500 | 2.500 | 2.800 | 1.200 |
| Dividend Payout Ratio (%) | 59.691% | -- | 49.505% | 31.017% | 39.437% | 28.708% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.117 | -- | 1.216 | 1.179 | 1.307 | 1.258 |
| Remarks: | Real time quote last updated: 12/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 142,035 |
| %Change | 1.244% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 1.117 |